Skip to content

Clinical trials

Lymphoma, Follicular trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Follicular Country / region: Taiwan Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20113
20135
20173
20193
20203
20215
20222
20235
20245
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting12
Recruiting6
Terminated6
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer4
Regeneron Pharmaceuticals4
AstraZeneca3
Epizyme, Inc.2
Genmab2
GenomeFrontier Therapeutics TW Co., Ltd.2
Gilead Sciences2
MEI Pharma, Inc.2
Novartis Pharmaceuticals2
Acepodia Biotech, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Follicular38
Lymphoma, Non-Hodgkin10
Lymphoma, B-Cell, Marginal Zone8
Bronchiolitis Obliterans Syndrome6
Recurrence6
Lymphoma, B-Cell5
Lymphoma, Large B-Cell, Diffuse5
Lymphoma4
Psoriasis4
Leukemia, Lymphocytic, Chronic, B-Cell3

Trials

Showing 26 to 38 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.